Clinical Trial: CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT05267886) titled 'CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock' on Feb. 3.

Brief Summary: The investigators are interested in determining if there is a meaningful benefit from the use of medications purported to increase the pumping function of the heart (i.e. inotropes) among critically ill patients admitted to the Cardiac Intensive Care Unit (CICU). To do this, the investigators will conduct a multi-centre, double blind, randomized control trial with patients who are deemed to require these medications by their treating physician to one of the two most commonly used agents in Canada (Milrinone or Dobutamine) or placebo. E...